ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2024年第一季度报告（更新后） | 2024-10-18 | Chinese | |
| 关于对广东证监局警示函整改报告的公告 | 2024-10-18 | Chinese | |
| 2022年年度报告摘要（更新后） | 2024-10-18 | Chinese | |
| 2023年第三季度报告（更新后） | 2024-10-18 | Chinese | |
| 资产减值管理制度 | 2024-10-18 | Chinese | |
| 关于与生物活性分子与成药性优化全国重点实验室签署《战略合作框架协议》的公告 | 2024-09-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 36041597 | 2024年第一季度报告（更新后） | 2024-10-18 | Chinese | ||
| 36041582 | 关于对广东证监局警示函整改报告的公告 | 2024-10-18 | Chinese | ||
| 36041571 | 2022年年度报告摘要（更新后） | 2024-10-18 | Chinese | ||
| 36041561 | 2023年第三季度报告（更新后） | 2024-10-18 | Chinese | ||
| 36041544 | 资产减值管理制度 | 2024-10-18 | Chinese | ||
| 36041536 | 关于与生物活性分子与成药性优化全国重点实验室签署《战略合作框架协议》的公告 | 2024-09-30 | Chinese | ||
| 36041528 | 股票交易异常波动公告 | 2024-09-25 | Chinese | ||
| 36041520 | 关于收到广东证监局警示函的公告 | 2024-09-13 | Chinese | ||
| 36041518 | 关于与UNIVERSITI KEBANGSAAN MALAYSIA及PHARMA MEDICAL SDN BHD.签署《战略合作框架协议》的公告 | 2024-09-12 | Chinese | ||
| 36041510 | 简式权益变动报告书（二） | 2024-09-11 | Chinese | ||
| 36041499 | 简式权益变动报告书（一） | 2024-09-11 | Chinese | ||
| 36041492 | 关于持股5%以上股东拟协议转让股份暨权益变动的提示性公告 | 2024-09-11 | Chinese | ||
| 36041485 | 简式权益变动报告书（三） | 2024-09-11 | Chinese | ||
| 36041480 | 关于参加广东辖区2024年投资者网上集体接待日暨中报业绩说明会的公告 | 2024-09-09 | Chinese | ||
| 36041472 | 关于完成公司经营范围工商变更登记的公告 | 2024-09-04 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.